THE INTERNATIONAL (MAINLY EUROPEAN) ATTITUDE TO THE DRUG DRIVING PROBLEM - LEGISLATION AND COUNTERMEASURES. MEDICINES AND ROAD TRAFFIC SAFETY

The state of drug-driving legislation and para-legal practice in Europe is that the reaction by individual countries varies according to their perceptions of the road safety problem likely to be due to drugs (medicines). Countermeasure actions range from the outright official banning of the use by drivers of certain listed medicines, through the reliance mainly on the suppliers (prescribing physicians, dental practitioners and the dispensing pharmacists) to pass on to patients advice on driving provided basically by the manufacturers for professional use, to virtually no action at all. What appears to be required to allow a more uniform approach throughout the zone is more detailed and constructive information on the impairment properties, either negative or positive, of the individual medicines. The provision of such information should provide the basis for, at least, more effective warning systems. The British national formulary committee recommends that the pharmacist put a fixed label on the container when he dispenses the medicine which, in the relevant instances, advises the person that he ought not to drive. This is being introduced throughout the country and students in pharmacy and medicine are being instructed to advise patients, when a drug is prescribed, whether they ought to drive or not. (TRRL)

  • Availability:
  • Corporate Authors:

    CNS (Clinical Neuroscience) Publishers

    50 Ferry Street, Isle of Dogs
    London,   England 
  • Authors:
    • IRVING, A
  • Publication Date: 1988

Media Info

Subject/Index Terms

Filing Info

  • Accession Number: 00493019
  • Record Type: Publication
  • Source Agency: Transport Research Laboratory
  • ISBN: 1-869868-02-1
  • Files: ITRD, TRIS
  • Created Date: May 31 1990 12:00AM